oxygen − dependent on its exposure duration − affects NSC expansion by regulating cell cycle length. Of note, already an exposure to atmospheric oxygen levels for a few hours dramatically shifts NSCs ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

The candidate, dubbed SIM0500, targets GPRC5D, BCMA and CD3 and is already in phase 1 trials for multiple myeloma in the U.S. and China. It’s not AbbVie’s first foray into T-cell engager ...

What is the moon phase today ... of its way through its lunar cycle and journey around the Earth. "People may casually call this a half moon, but remember, that's not really what you're witnessing ...

A study published by the Journal of Traditional and Complementary Medicine and e-published by the U.S. National Library of ...

Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk ...

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...

Age makes a difference to hair and nail growth, even in healthy people. Younger people generally have faster growth rates ...